Generic Medicine Info
May be taken with or without food.
Severe CV disorder or recent history of stroke or MI (within the last 6 months), unstable angina, retinitis pigmentosa, vision loss due to non-arteritic anterior ischaemic optic neuropathy (NAION), ESRD requiring dialysis, hypotension <90/50 mmHg, and other conditions wherein sexual intercourse is inadvisable. Severe hepatic impairment (Child-Pugh class C). Concomitant use with any form of organic nitrates/nitrites, guanylate cyclase stimulators.
Special Precautions
Patient with CV disease, left ventricular outflow obstruction (aortic stenosis or hypertrophic obstructive cardiomyopathy), anatomical penile deformation, conditions which may predispose to priapism (e.g. sickle cell anaemia, multiple myeloma, leukaemia); bleeding disorders, peptic ulcer disease. Severe renal and mild to moderate hepatic impairment. Elderly. Pregnancy and lactation. Patient Counselling This medicine may cause dizziness and blurred vision, if affected, do not drive or operate machinery. Monitoring Parameters Assess CV status prior to initiation of therapy. Monitor BP, heart rate, renal function, and LFT.
Adverse Reactions
Significant: Hypotension, color discrimination impairment, vision loss/NAION, sudden decrease or loss of hearing, tinnitus. Rarely, prolonged/painful erection or priapism. Gastrointestinal disorders: Dyspepsia, nausea. General disorders and administration site conditions: Flu-like symptoms. Nervous system disorders: Headache, dizziness. Respiratory, thoracic and mediastinal disorders: Nasal congestion, sinusitis.
Drug Interactions
May enhance hypotensive effect of α-blockers. Increased serum concentration with guanylate cyclase stimulators (e.g. riociguat), potent CYP3A4 inhibitors (e.g. ketoconazole) and moderate CYP3A4 inhibitors (e.g. clarithromycin), HIV protease inhibitors (e.g. ritonavir). May prolong Qt interval with class IA (e.g. quinidine, procainamide) or class III (e.g. amiodarone, sotalol) antiarrhythmics.
CIMS Class
Drugs for Erectile Dysfunction
ATC Classification
G04BE09 - vardenafil ; Belongs to the class of drugs used in erectile dysfunction.
Disclaimer: This information is independently developed by CIMS based on vardenafil from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in